Key result
A pharmacist-managed hypertension clinic significantly lowered blood pressure (P<0.001) and yielded lower cost-effectiveness ratios ($27 vs $193/mm Hg for systolic BP) compared to physician care.
Why the study?
Does a pharmacist-managed hypertension clinic improve clinical, economic, and humanistic outcomes compared to physician-managed clinics in patients with mild-to-moderate essential hypertension?
RCT (n=330)
Does a pharmacist-managed hypertension clinic improve clinical, economic, and humanistic outcomes compared to physician-managed clinics in patients with mild-to-moderate essential hypertension?
Pharmacist-managed hypertension clinics provide superior blood pressure control and patient satisfaction at similar total costs compared to physician-managed clinics, resulting in better cost-effectiveness.
Answers are grounded in this paper and cite their sources.
Supports pharmacist-managed hypertension clinics for better BP control and cost-effectiveness; extends RCT evidence for team-based hypertension care.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Okamoto et al. (2001) conducted an RCT in mild-to-moderate essential hypertension (n=330). Pharmacist-managed hypertension clinic vs. Physician-managed general medical clinics was evaluated on Blood pressure measurements (p=<0.001). A pharmacist-managed hypertension clinic significantly lowered blood pressure (P<0.001) and yielded lower cost-effectiveness ratios ($27 vs $193/mm Hg for systolic BP) compared to physician care.
Synapse has enriched 10 related papers. Consider them for comparative context: